WI
GILD icon

Wintrust Investments’s Gilead Sciences GILD Stock Holding History

Wintrust Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,500
Closed -$120K – 295
2016
Q4 		$120K Buy
+1,500
New +$111K 0.05% 210

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wintrust Investments's GILD Position: Q4 2024 in Review

Wintrust Investments reduced its Gilead Sciences (GILD) stake by 40% in Q4 2024, selling an estimated $19.7K and leaving 329 shares worth $30K. The position accounts for 0.03% of the portfolio, ranked #323.

Wintrust Investments first reported a position in GILD in Q2 2016 and has held it in 34 quarters since. The position peaked at $10.2M in Q2 2021. 1,888 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • Wintrust Investments held 329 shares of Gilead Sciences worth $30K as of Q4 2024.
  • Wintrust Investments sold 219 Gilead Sciences shares in Q4 2024, an estimated $19.7K.
  • Gilead Sciences made up 0.03% of Wintrust Investments's portfolio in Q4 2024, its #323 holding.
  • Wintrust Investments first reported a position in Gilead Sciences in Q2 2016 and has held it in 34 quarters since.
  • Wintrust Investments's Gilead Sciences position peaked at $10.2M in Q2 2021.
  • 1,888 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Wintrust Investments's 13F filing for Q4 2024, filed 10 Feb 2025.